Compare ABCL & KALU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABCL | KALU |
|---|---|---|
| Founded | 2012 | 1946 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 3.0B |
| IPO Year | 2020 | 2006 |
| Metric | ABCL | KALU |
|---|---|---|
| Price | $12.61 | $151.85 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | $8.40 | ★ $147.33 |
| AVG Volume (30 Days) | ★ 4.4M | 145.9K |
| Earning Date | 05-11-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 1.78% |
| EPS Growth | 10.91 | ★ 135.89 |
| EPS | N/A | ★ 9.43 |
| Revenue | $75,128,000.00 | ★ $1,585,900,000.00 |
| Revenue This Year | N/A | $13.37 |
| Revenue Next Year | $21.85 | $2.62 |
| P/E Ratio | ★ N/A | $16.01 |
| Revenue Growth | ★ 160.56 | N/A |
| 52 Week Low | $2.75 | $73.08 |
| 52 Week High | $13.18 | $199.89 |
| Indicator | ABCL | KALU |
|---|---|---|
| Relative Strength Index (RSI) | 65.97 | 42.11 |
| Support Level | $10.38 | $116.89 |
| Resistance Level | N/A | $196.37 |
| Average True Range (ATR) | 0.61 | 5.67 |
| MACD | -0.01 | -0.54 |
| Stochastic Oscillator | 79.02 | 17.68 |
AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.
Kaiser Aluminum Corp specializes in the production of semi-fabricated specialty aluminum mill products, such as aluminum plate and sheet, bare and coated coil and extruded and drawn products, for the end market applications: Aero/HS Products; Packaging; GE Products; and Automotive Extrusions. Its products include fabricated aluminum mill products such as flat-rolled (plate, sheet, and coil), extruded (rod, bar, hollows, and shapes), drawn (rod, bar, pipe, tube and wire) and certain cast aluminum products. Geographically, the company generates majority of its revenue from the United States.